Needham analyst Chad Messer lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Ionis Pharmaceuticals (IONS) PT Lowered to $90 at BofA SecuritiesJuly 9, 2026 11:54 AM Ionis Pharmaceuticals (IONS) PT Lowered to $94 at TD CowenJuly 9, 2026 11:53 AM Ionis Pharmaceuticals (IONS) PT Lowered to $92 at OppenheimerJuly 9, 2026 9:42 AM Stifel: 'We expect IONS shares to trade lower today and ALNY shares to be volatile'July 9, 2026 6:16 AM Ionis drug eplontersen misses primary endpoint in heart trialJuly 9, 2026 2:00 AM Update on CARDIO-TTRansform Phase 3 trial of eplontersen in adults with transthyretin-mediated amyloid cardiomyopathyJuly 9, 2026 2:00 AM